FUT8 and prostate cancer: The upregulated expression of FUT8 has been reported in several cancers, including lung cancer [6], prostate cancer [7], hepatocellular carcinoma (HCC) [8–10] and CRC [11], demonstrating that FUT8 is involved in biological tumor characteristics and patient outcomes.